Charles Schwab Investment Management Inc Verrica Pharmaceuticals Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 43,653 shares of VRCA stock, worth $347,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,653
Previous 51,290
14.89%
Holding current value
$347,041
Previous $407,000
14.74%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VRCA
# of Institutions
79Shares Held
26.1MCall Options Held
9.9KPut Options Held
6.5K-
Armistice Capital, LLC New York, NY8.92MShares$70.9 Million1.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.25MShares$25.8 Million0.86% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.59MShares$20.6 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$14.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...